WO2001064638A1 - VERFAHREN ZUR HERSTELLUNG VON β-ALANINAMIDEN - Google Patents
VERFAHREN ZUR HERSTELLUNG VON β-ALANINAMIDEN Download PDFInfo
- Publication number
- WO2001064638A1 WO2001064638A1 PCT/EP2001/002349 EP0102349W WO0164638A1 WO 2001064638 A1 WO2001064638 A1 WO 2001064638A1 EP 0102349 W EP0102349 W EP 0102349W WO 0164638 A1 WO0164638 A1 WO 0164638A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hydrogen
- general formula
- alkyl
- formula
- optionally substituted
- Prior art date
Links
- 0 *C(N(*)C(CC#N)=O)I Chemical compound *C(N(*)C(CC#N)=O)I 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/14—Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/19—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Definitions
- the invention relates to a process for the preparation of amides of ⁇ -alanine, in particular dipeptides such as carnosine. It further relates to new cyanoacetic acid amides as intermediates in the ner process according to the invention.
- Carnosine (ß-alanyl-L-histidine) is a naturally occurring dipeptide of the structure below, which can be isolated from muscle tissue. Carnosine is of interest as a potential therapeutic agent and more recently as a dietary supplement with an antioxidant effect.
- the object of the present invention was therefore to provide a process which is suitable for the industrial synthesis of carnosine and other dipeptides of ⁇ -alanine and which does not require the use of protective groups or expensive derivatives and uses only readily accessible starting materials.
- ⁇ -alaninamides which can be prepared according to the invention have the general formula
- R 1 is hydrogen or C 1--6 alkyl which is optionally substituted by hydroxy, amino, carboxy, carbamoyl, methylmercapto, guanidino, optionally substituted aryl or heteroaryl and R 2 is hydrogen or R 1 and R 2 together form a group of the formula - (CH 2 ) plague-, where n is 3 or 4.
- the compounds can also exist in several tautomeric forms or as a mixture of such forms. If R 1 is different from hydrogen, the ⁇ -alanine amides (I) contain at least one asymmetry center. Formula I comprises both all possible stereoisomers and their mixtures.
- -e-alkyl means all linear or branched primary, secondary or tertiary alkyl groups with 1 to 6 carbon atoms, for example methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, isobutyl, Pentyl, isopentyl, neopentyl, 2-methylbutyl, hexyl, 2-methylpentyl, 3-methylpentyl etc.
- C ⁇ _ ⁇ o- alkyl which includes, for example, groups such as octyl or 2-ethylhexyl in addition to those already mentioned.
- Aryl is to be understood as meaning mono- or polycyclic carbocyclic aromatic groups, such as, in particular, phenyl or naphthyl; heteroaryl is understood to mean correspondingly mono- or polycyclic heterocyclic aromatic groups with one or more hetero atoms, in particular imidazolyl or indolyl.
- Aryl groups can optionally also carry one or more of the abovementioned substituents, in particular hydroxyl groups such as, for example, in 4-hydroxyphenyl.
- Monovalent inorganic cations are, for example, the alkali metal ions such as Li + , Na + , K + , Rb + and Cs + .
- Polyvalent inorganic cations are, for example, the alkaline earth metal ions such as Mg, Ca, Sr and Ba.
- Organic cations are, for example, quaternary ammonium ions.
- R 1 , R 2 and R 3 have the meanings given above, with a cyanoacetic ester of the general formula
- R 4 is C ⁇ _ ⁇ o- alkyl, to a cyanoacetamide of the general formula
- R 1 , R 2 and R 3 have the meanings given above, or a corresponding salt can be reacted and the cyanoacetic acid amide (IV) can be converted into the target compound (I) or a corresponding salt by catalytic hydrogenation.
- R 1 is preferably hydrogen or optionally substituted C 1--4 -alkyl, in particular methyl, isopropyl, isobutyl, .ec-butyl, indol-3-ylmethyl, benzyl, -hydroxybenzyl, 2- (methylsulfanyl) ethyl, hydroxymethyl, 1- Hydroxy ethyl, carbamoylmethyl, 2-carbamoylethyl, carboxymethyl, 2-carboxyethyl, 4-aminobutyl or 3-guanidino-propyl.
- R 2 is preferably hydrogen.
- R 1 is particularly preferably imidazol-4-ylmethyl or 3-methylimidazol-4-ylmethyl and R 2 is hydrogen.
- R 4 is preferably methyl or ethyl.
- the ⁇ -amino acid or its ester (II) is present as an inner salt or salt in which the ⁇ -amino group is protonated, it must first be deprotonated by adding a base.
- a base Basically, all bases that have a stronger basicity than the ⁇ -amino group of the amino acid (II) can be used as the base.
- a medium to strong base is preferably used.
- alkali metal hydroxides such as sodium or potassium hydroxide
- tertiary amines such as triethylamine
- 4-dimethylaminopyridine 1,4-diaza [2.2.2] bicyclooctane
- bicyclic amidines (“DBN”, “DBU”)
- alkali metal alcoholates in non-aqueous solvents such as sodium methoxide or ethanolate and in aprotic solvents also alkali metal hydrides and amides such as sodium hydride or amide.
- the base is preferably used in a stoichiometric or approximately stoichiometric amount.
- Preferred solvents for the first stage are polar protic or aprotic solvents such as water, C 1-- alkanols such as methanol or ethanol, and amides such as N, N-dimethylformamide, N, N-dimethylacetamide, l-methyl-2-pyrrolidone or 1,3-dimethyl-3,4,5,6-tetrahydro-2 (1H) pyrimidmon (DMPU).
- polar protic or aprotic solvents such as water, C 1-- alkanols such as methanol or ethanol
- amides such as N, N-dimethylformamide, N, N-dimethylacetamide, l-methyl-2-pyrrolidone or 1,3-dimethyl-3,4,5,6-tetrahydro-2 (1H) pyrimidmon (DMPU).
- Metal catalysts based on nickel, cobalt, copper, rhodium, palladium, ruthenium or platinum, which are optionally supported on a support, are preferably used as catalysts for the hydrogenation. These include, for example, nickel and Raney-type cobalt catalysts, finely divided platinum (e.g. obtained by reduction of PtO 2 ), rhodium, palladium or platinum on activated carbon or aluminum oxide or cobalt on silicon dioxide (silica).
- Raney nickel and Raney cobalt and rhodium on activated carbon or aluminum oxide are particularly preferred.
- the solvents used in the hydrogenation can be the solvents which are customary in the hydrogenation of nitriles to amines, such as, for example, water, concentrated aqueous ammonia solution, methanol, ethanol, N, N-dimethylformamide or mixtures of the solvents mentioned.
- R 1 , R 2 and R 3 have the meanings given above, and their salts are new and also a subject of the invention.
- Preferred cyanoacetic acid amides (IV) are those in which R 1 is optionally substituted imidazol-4-ylmethyl and R 2 is hydrogen. Possible substituents here are, for example, C 6 alkyl groups, in particular methyl.
- Particularly preferred cyanoacetic acid amides (IV) are ⁇ - (Cyanacety ⁇ -L-histidine and its esters of the formula
- R 3 has the meaning given above, and their salts and tautomers and ⁇ - (cyanoacetyl ⁇ methyl-L-histidine and its esters of the formula
- the optical purity was determined to be> 99.8% on a sample obtained in accordance with the above specification.
- the determination was carried out by hydrolysis of the amide bond (6 N hydrochloric acid, 110 ° C., 24 h), followed by derivatization of the released histidine with trifluoroacetic anhydride and isobutyl chloroformate. By means of gas chromatography on a chiral stationary phase, a content of D-histidine of ⁇ 0.1% was detected.
- the mixture was hydrogenated at 110 ° C. and 45 bar for 1 h.
- the catalyst was then filtered off and the filtrate was adjusted to pH 8.2 with formic acid.
- the residue was slurried in 200 ml of ethanol and heated to 60 ° C. for 30 minutes.
- the product was filtered off, washed successively with ethanol, ethyl acetate and diethyl ether and finally dried.
- reaction mixture After a one-hour post-reaction at 90 ° C, the reaction mixture was cooled to room temperature. The autoclave was depressurized and the catalyst was filtered off over activated carbon. An HPLC in-process analysis showed that the clear greenish reaction solution (326.2 g) contained 5.74% (m / m) carnosine, which corresponds to a selectivity of 92% when conversion is complete. The reaction mixture was then concentrated on a rotary evaporator to about 60 g. The dropwise addition of 174 g of ethanol precipitated a white solid, which was filtered off and dried at 50 ° C./20 mbar. Yield: 13.0 g (64%)
- Example 7 The procedure was as described in Example 7, with the difference that 5% Rh on aluminum oxide was used as the catalyst. Under these conditions, L-carnosine was formed with 83% selectivity.
- reaction solution (590.8 g) contained 4.68% (mim) carnosine, which corresponds to a selectivity of 91% when conversion is complete.
- reaction mixture After a one-hour post-reaction at 100 ° C, the reaction mixture was cooled to room temperature. The autoclave was depressurized and the catalyst was filtered off. A ⁇ PLC in-process analysis showed that the reddish brown reaction solution (310.5 g) contained 9.57% (m / m) carnosine, which corresponds to a selectivity of 97% when conversion is complete.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pyrrole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001262081A AU2001262081A1 (en) | 2000-03-03 | 2001-03-02 | Method for producing beta-alaninamides |
US10/220,608 US6878829B2 (en) | 2000-03-03 | 2001-03-02 | Method for producing β-alaninamides |
JP2001563481A JP2004509834A (ja) | 2000-03-03 | 2001-03-02 | β−アラニンアミドの製造方法 |
EP01936057A EP1259483B1 (de) | 2000-03-03 | 2001-03-02 | Verfahren zur herstellung von beta-alaninamiden |
DE50113860T DE50113860D1 (de) | 2000-03-03 | 2001-03-02 | Verfahren zur herstellung von beta-alaninamiden |
US11/102,828 US7164028B2 (en) | 2000-03-03 | 2005-04-11 | Method for preparing β-alaninamides |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00104643 | 2000-03-03 | ||
EP00104643.2 | 2000-03-03 | ||
US27169401P | 2001-02-28 | 2001-02-28 | |
US60/271,694 | 2001-02-28 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10220608 A-371-Of-International | 2001-03-02 | ||
US11/102,828 Division US7164028B2 (en) | 2000-03-03 | 2005-04-11 | Method for preparing β-alaninamides |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001064638A1 true WO2001064638A1 (de) | 2001-09-07 |
Family
ID=8168028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/002349 WO2001064638A1 (de) | 2000-03-03 | 2001-03-02 | VERFAHREN ZUR HERSTELLUNG VON β-ALANINAMIDEN |
Country Status (6)
Country | Link |
---|---|
US (2) | US6878829B2 (de) |
EP (1) | EP1259483B1 (de) |
JP (1) | JP2004509834A (de) |
AT (1) | ATE392413T1 (de) |
AU (1) | AU2001262081A1 (de) |
WO (1) | WO2001064638A1 (de) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003022795A1 (de) * | 2001-09-06 | 2003-03-20 | Lonza Ag | Verfahren zur herstellung von beta-alaninamiden |
KR20200050946A (ko) | 2017-09-05 | 2020-05-12 | 가부시끼가이샤 도꾸야마 | 보호 l-카르노신 유도체, l-카르노신, 및 결정성 l-카르노신 아연착체의 제조 방법 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107602661B (zh) * | 2017-08-24 | 2020-03-17 | 烟台万润药业有限公司 | 一种聚普瑞锌的制备方法 |
CN114213335B (zh) * | 2021-12-23 | 2023-08-15 | 浙江湃肽生物股份有限公司 | 肌肽中间体及其肌肽的制备、用途 |
CN114573470B (zh) * | 2022-03-17 | 2023-12-15 | 浙江海洲制药有限公司 | 一种合成n-三氟乙酰叔亮氨酸的方法 |
CN116283604A (zh) * | 2022-12-25 | 2023-06-23 | 苏州永健生物医药有限公司 | 一种亚精胺的制备方法 |
CN117164519A (zh) * | 2023-08-18 | 2023-12-05 | 杭州小蓓医药科技有限公司 | 一种l-肌肽的合成方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1500576A (en) * | 1974-04-09 | 1978-02-08 | Ciba Geigy Ag | Amides and their use as fungicides |
US4359416A (en) * | 1981-07-13 | 1982-11-16 | Pfizer Inc. | Process for preparing L-carnosine |
EP0294668A2 (de) * | 1987-06-09 | 1988-12-14 | Bayer Ag | (2-Cyan-2-oximinoacetyl)-aminosäure-Derivate |
WO1991005555A2 (en) * | 1989-10-13 | 1991-05-02 | The Salk Institute Biotechnology/Industrial Associates, Inc. | N-acyl peptide metalloendopeptidase inhibitors and methods of using same |
US5112751A (en) * | 1991-02-06 | 1992-05-12 | Board Of Governors Of Wayne State University | Method for inactivating dehydropepidase activity irreversibly with alkenoic acid compounds |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4204002A (en) * | 1974-04-09 | 1980-05-20 | Ciba-Geigy Corporation | Methods of using N-(substituted)-N-alkoxy carbonyl anilino compounds |
US4093738A (en) * | 1974-04-09 | 1978-06-06 | Ciba-Geigy Corporation | Microbicidally-active acylated anilino-carboxylic acid esters and their compositions |
DE3124091C2 (de) * | 1981-06-19 | 1983-06-01 | Degussa Ag, 6000 Frankfurt | N-(3-Cyanopropanoyl)-aminocarbonsäureester und deren Verwendung |
DE3702282A1 (de) * | 1987-01-27 | 1988-08-04 | Bayer Ag | 2-cyan-2-oximino-acetamide |
US5238930A (en) * | 1991-02-06 | 1993-08-24 | Board Of Governors Of Wayne State University | Alkenoic acid compounds for mechanism-based inactivation of dehydropeptidase activity |
DE4114238A1 (de) * | 1991-04-26 | 1992-10-29 | Zentralinstitut Fuer Organisch | Neue substituierte 2,2 -pentamethylen-(delta)(pfeil hoch)3(pfeil hoch)-imidazolin-5-one bzw. 2,2 -pentamethylen-imidazolidin-5-one und verfahren zu deren herstellung |
US5238893A (en) * | 1991-12-30 | 1993-08-24 | Bridgestone Corporation | Method of preparing an anionic polymerization initiator |
-
2001
- 2001-03-02 US US10/220,608 patent/US6878829B2/en not_active Expired - Fee Related
- 2001-03-02 EP EP01936057A patent/EP1259483B1/de not_active Expired - Lifetime
- 2001-03-02 AT AT01936057T patent/ATE392413T1/de not_active IP Right Cessation
- 2001-03-02 AU AU2001262081A patent/AU2001262081A1/en not_active Abandoned
- 2001-03-02 WO PCT/EP2001/002349 patent/WO2001064638A1/de active IP Right Grant
- 2001-03-02 JP JP2001563481A patent/JP2004509834A/ja active Pending
-
2005
- 2005-04-11 US US11/102,828 patent/US7164028B2/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1500576A (en) * | 1974-04-09 | 1978-02-08 | Ciba Geigy Ag | Amides and their use as fungicides |
US4359416A (en) * | 1981-07-13 | 1982-11-16 | Pfizer Inc. | Process for preparing L-carnosine |
EP0294668A2 (de) * | 1987-06-09 | 1988-12-14 | Bayer Ag | (2-Cyan-2-oximinoacetyl)-aminosäure-Derivate |
WO1991005555A2 (en) * | 1989-10-13 | 1991-05-02 | The Salk Institute Biotechnology/Industrial Associates, Inc. | N-acyl peptide metalloendopeptidase inhibitors and methods of using same |
US5112751A (en) * | 1991-02-06 | 1992-05-12 | Board Of Governors Of Wayne State University | Method for inactivating dehydropepidase activity irreversibly with alkenoic acid compounds |
Non-Patent Citations (1)
Title |
---|
R O C NORMAN: "Principles of Organic Synthesis", 1968, METHUEN & CO LTD / SCIENCE PAPERBACKS, LONDON, XP002172715 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003022795A1 (de) * | 2001-09-06 | 2003-03-20 | Lonza Ag | Verfahren zur herstellung von beta-alaninamiden |
US7358393B2 (en) | 2001-09-06 | 2008-04-15 | Lonza Ltd. | Method for preparing β-alaninamides |
KR20200050946A (ko) | 2017-09-05 | 2020-05-12 | 가부시끼가이샤 도꾸야마 | 보호 l-카르노신 유도체, l-카르노신, 및 결정성 l-카르노신 아연착체의 제조 방법 |
Also Published As
Publication number | Publication date |
---|---|
EP1259483A1 (de) | 2002-11-27 |
AU2001262081A1 (en) | 2001-09-12 |
ATE392413T1 (de) | 2008-05-15 |
EP1259483B1 (de) | 2008-04-16 |
US20030105335A1 (en) | 2003-06-05 |
JP2004509834A (ja) | 2004-04-02 |
US7164028B2 (en) | 2007-01-16 |
US20050192354A1 (en) | 2005-09-01 |
US6878829B2 (en) | 2005-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1778668B1 (de) | Verfahren zur herstellung von dihydropteridinonen | |
WO2001017998A2 (de) | Verfahren zur herstellung substituierter pyrimidinderivate | |
EP3421470A1 (de) | Substituierte 5-fluor-1h-pyrazolopyridine in kristalliner form | |
US7164028B2 (en) | Method for preparing β-alaninamides | |
DE69313771T3 (de) | Carbazolon - Derivate und Verfahren zu ihrer Herstellung | |
EP2099773A1 (de) | Neues verfahren zur herstellung von 4,4'-(1-methyl-1,2-ethandiyl)-bis-(2,6-piperazindion) | |
DE60029803T2 (de) | Verfahren für die herstellung von 4(5)-amino-5(4)-carboxamidoimidazolen und deren zwischenprodukte | |
EP1607090B1 (de) | Asimadolin für die Behandlung des Irritable Bowel Syndroms | |
EP0371499A2 (de) | Verfahren zur Herstellung von Pyridin-2,3-dicarbonsäureestern | |
EP0252353B1 (de) | 4-Benzyloxy-3-pyrrolin-2-on-1-yl-acetamid, dessen Herstellung und Verwendung | |
EP1430018B1 (de) | Verfahren zur herstellung von beta-alaninamiden | |
DE1620381A1 (de) | Derivate des 2-Aminopyrazins und Verfahren zu ihrer Herstellung | |
DE2409675A1 (de) | Alpha-alkyl(oder -aryl)-thio-5-hydroxytryptophan-derivat und verfahren zu seiner herstellung | |
DE2659851C3 (de) | Verfahren zur Herstellung von 2-Phenyl-4-hydroxymethylimidazolen | |
EP0704429B1 (de) | 2-(Arylimino-methyl)-3-(di-substituierte-amino)-alcylnitrile, Verfahren zu ihrer Herstellung und ihre Verwendung | |
DE3907508A1 (de) | Verfahren und zwischenprodukte, gegebenenfalls n-substituierte, (2-(nitro)-phenyl)-methylenimine zur herstellung von 1,4-di-(hydro)-2,6-di-(methyl)-4-(2'-(nitro) -phenyl)-pyridin-3,5-di-(carbonsaeure- dimethylester) sowie verfahren zur herstellung dieser zwischenprodukte | |
EP0015516B1 (de) | Verfahren zur Herstellung von 5-Hydroxymethylimidazolen | |
DE68917994T2 (de) | Verfahren zur Herstellung von Pyrrolizinderivaten. | |
EP3507271B1 (de) | Verfahren zur herstellung von salicyloyl-l-carnitin-hydrochlorid | |
DE3200258A1 (de) | Substituierte 1-benzoyl-2-phenylimino-imidazolidine, deren saeureadditionssalze, verfahren zu deren herstellung und diese enthaltende arzneimittel | |
DE2814355B2 (de) | Verfahren zur Herstellung von 4-Methyl-5- [(2aminoäthyl)-thiomethyl] -imidazol-dihydrochlorid | |
DE2340409A1 (de) | 1h-tetrazol-1-essigsaeure und deren ester, sowie verfahren zu deren herstellung | |
EP0377437A1 (de) | Verfahren zur Herstellung von 2,4-Diamino-6-piperidinyl-pyrimidin-3-N-oxid | |
DE2345775C3 (de) | Enaminsulfoxide und Verfahren zu ihrer Herstellung | |
DE60114170T2 (de) | Verfahren zur Herstellung von Decahydro-2a,4a,6a,8a-tetraazacyclopen(fg)acenaphthylen und von verwandten Derivaten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001936057 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 563481 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10220608 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2001936057 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001936057 Country of ref document: EP |